February 26, 2021

Market and Financial News Aggregator

Bristol-Myers, Sanofi ordered to pay Hawaii $834 million over Plavix warning label By Reuters

3 min read

© Reuters. FILE PHOTO: Bottles of Plavix shown on display at a pharmacy in North Aurora, Illinois.

By Tina Bellon and Nate Raymond

(Reuters) – A judge in Hawaii on Monday ordered Bristol-Myers Squibb (NYSE:) Co and Sanofi (NASDAQ:) SA to pay more than $834 million to the state for failing to warn non-white patients properly of health risks from its blood thinner Plavix.

Judge Dean Ochiai in Honolulu concluded the companies engaged in unfair and deceptive business practices from 1998 to 2010 by failing to change the drug’s label to warn doctors and patients despite knowing some of the risks.

Hawaii Attorney General Clare Connors, whose office sued the companies in 2014, said the ruling “puts the pharmaceutical industry on notice that it will be held accountable for conduct that deceives the public and places profit above safety.”

Bristol-Myers and Sanofi, which produced Plavix in a partnership, in a joint statement vowed to appeal, saying the decision was “unsupported by the law and at odds with the evidence at trial.” They called Plavix safe and effective.

Ochiai, who presided over a four-week, non-jury trial conducted entirely over Zoom due to the COVID-19 pandemic, ordered Bristol-Myers and Sanofi to each pay $417 million in penalties.

Hawaii alleged the companies violated state consumer protection laws by marketing Plavix without disclosing that the drug could have a diminished or no effect for some people, particularly of East Asian and Pacific Island ancestry.

Plavix is prescribed to prevent strokes and heart attacks. The blood thinner needs to be activated by the body’s own enzymes, which can vary genetically.

Studies have shown that about 14% of Chinese patients are unable to metabolize the drug properly, compared with 4% of Black and 2% of white patients.

The U.S. Food and Drug Administration in 2010 issued a new Plavix warning label to reflect that information.

Bristol-Myers and Sanofi still face a similar lawsuit over Plavix by the state of New Mexico.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Reuters

2021-02-15 23:05:25

All news and articles are copyrighted to the respective authors and/or News Broadcasters. VIXC.Com is an independent Online News Aggregator


Read more from original source here…

Leave a Reply

Copyright © All rights reserved. | Newsphere by AF themes.